Tetrabenazine, Depression and Suicide: Good News

Journal of Huntington's Disease

Volumn 3, Issue 2, 2014, Pages 137-138

  Margolis, Russell L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TETRABENAZINE; ADRENERGIC RECEPTOR AFFECTING AGENT;

DEPRESSION; DRUG EFFICACY; DYSTONIA; EVIDENCE BASED PRACTICE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUNTINGTON CHOREA; MYOCLONUS; NOTE; OFF LABEL DRUG USE; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SUICIDE; SUICIDE ATTEMPT; TARDIVE DYSKINESIA; TIC; UNIFIED HUNTINGTON DISEASE RATING SCALE; ARTICLE; CHEMICALLY INDUCED DISORDER; PSYCHOLOGICAL ASPECT;

ADRENERGIC UPTAKE INHIBITORS; DEPRESSION; HUMANS; HUNTINGTON DISEASE; SUICIDE; TETRABENAZINE;

EID: 84907209779     PISSN: 18796397     EISSN: 18796400     Source Type: Journal    
DOI: 10.3233/JHD-140107     Document Type: Note

References (8)

1. Guay DR. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Am J Geriatr Pharmacother. 2010;8:331-73.
2. Chen JJ, Ondo WG, Dashtipour K, Swope DM. Tetrabenazine for the treatment of hyperkineticmovement disorders:Areview of the literature. Clin Ther. 2012;34(7):1487-504.
3. Adam OR, Jankovic J. Symptomatic treatment of Huntington disease. Neurotherapeutics. 2008;5(2):181-97.
4. http://www.xenazineusa.com/hcp/prescribingxenazine; see also REMS statement, most recent modification: August 2013 NDA 21-894, Xenazine®, Valeant Pharmaceuticals North America LLC http://www.fda.gov/downloads/Drugs/DrugSafe ty/PostmarketDrugSafetyInformationforPatientsandProviders/ ucm129514.pdf
5. Huntington Study Group. Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial. Neurology. 2006;66(3):366-372.
6. Schoenfeld M, Myers RH, Cupples LA, Berkman B, Sax DS, Clark E. Increased rate of suicide among patients with Huntington's disease. J Neurol Neurosurg Psychiatr. 1984;47(12):1283-7.
7. Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R, McDowell B, Turner B. Depression and stages of Huntington's disease. J Neuropsychiatry Clin Neurosci. 2005;17(4):496-502.
8. Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AF, Biglan KM, Shoulson I; Huntington Study Group COHORT Investigators. Natural history of Huntington disease. JAMA Neurol. 2013;70(12):1520-30